| Wednesday, 27 April 2016 |
| 09:00 - 17:30 | WEDNESDAY 27 APRIL 2016 |
| 07:15 - 08:45 | Industry symposium: Bristol Myers Squibb: Sliding doors: Different choices, different outcomes [Click here for details] |
| 07:15 - 08:45 | Industry symposium: Janssen: Raising the bar: Practical approaches to improving patient outcomes in PsA & RA [Click here for details] |
| 09:00 - 10:30 | Engaging with South Asian community in rheumatology care [Click here for details] |
| 09:00 - 10:30 | BSI: How targeted therapies reveal the immunology of autoimmune rheumatic disease [Click here for details] |
| 09:00 - 10:30 | Essentials: Disease management [Click here for details] |
| 09:00 - 10:30 | Dermatological manifestations in rheumatic disease: all you need to know [Click here for details] |
| 09:00 - 10:30 | Common musculoskeletal foot problems in primary care [Click here for details] |
| 09:00 - 10:30 | Osteoarthritis and osteoporosis oral abstracts [Click here for details] |
| 09:00 - 10:30 | BSR clinical guidelines [Click here for details] |
| 09:00 - 10:30 | BRiTs: How to survive as a consultant: all the things you need to know [Click here for details] |
| 09:00 - 10:30 | Workshop: Assessing disease activity and damage in vasculitis [Click here for details] |
| 10:30 - 11:30 | Coffee, exhibition and poster viewing |
| 10:30 - 11:30 | Innovation session: Eli Lilly: Targeting inflammatory pathways in RA: how can we progress from bench to bedside? [Click here for details] |
| 11:30 - 13:00 | BSI: Imaging immunology and inflammation in action [Click here for details] |
| 11:30 - 13:00 | Essentials: Symptom management [Click here for details] |
| 11:30 - 13:00 | BHPR oral abstracts [Click here for details] |
| 11:30 - 13:00 | Foot problems in inflammatory arthritis [Click here for details] |
| 11:30 - 13:00 | Connective tissue diseases and muscle disorders oral abstracts [Click here for details] |
| 11:30 - 13:00 | Group clinics in musculoskeletal disease: better together [Click here for details] |
| 11:30 - 13:00 | Lung disease special interest group [Click here for details] |
| 11:30 - 13:00 | ARMA: MSK comes of age: person-centred, coordinated care for improved outcomes through co-production and multidisciplinary working [Click here for details] |
| 13:00 - 14:30 | BSR AGM |
| 13:00 - 14:30 | Innovation session: Mallinckrodt Specialty Pharmaceuticals: ACTH: another option for acute gout uncovered [Click here for details] |
| 13:00 - 14:30 | Lunch |
| 14:30 - 16:00 | Treating early RA to target: practice outside the UK [Click here for details] |
| 14:30 - 16:00 | BSI: The role of RNA species and RNA binding proteins in the joint [Click here for details] |
| 14:30 - 16:00 | Essentials: Experts in the field [Click here for details] |
| 14:30 - 16:00 | Heritable disorders of connective tissue special interest group [Click here for details] |
| 14:30 - 16:00 | Primary care oral abstracts [Click here for details] |
| 14:30 - 16:00 | Supporting self-management for musculoskeletal health [Click here for details] |
| 14:30 - 16:00 | Disease modification in osteoarthritis [Click here for details] |
| 14:30 - 16:00 | Scleroderma special interest group [Click here for details] |
| 14:30 - 16:00 | Workshop: Assessing disease activity and damage in vasculitis [Click here for details] |
| 16:00 - 16:30 | Coffee and exhibition |
| 16:00 - 16:30 | Innovation session: Abbvie: Targeted Ultrasound Initiative (TUI) MSUS: An integral part of routine practice? [Click here for details] |
| 16:30 - 17:30 | Heberden Oration [Click here for details] |
| 17:30 - 19:15 | International delegates' reception |
| 17:30 - 19:15 | Trainee reception |
| 17:30 - 19:15 | Industry symposium: Pfizer: Signalling the future: JAK inhibition in Rheumatoid Arthritis treatment [Click here for details] |
| 17:30 - 19:15 | Industry symposium: Novartis: Targeted Management of AS & PsA [Click here for details] |
| 19:45 - 23:45 | Conference dinner |
